Antimicrobial treatment of lower respiratory tract infections in the hospital setting

Ronald F. Grossman, John C. Rotschafer, James S. Tan

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Respiratory tract infections (RTIs) that may require hospitalization include acute exacerbations of chronic bronchitis (AECB), community-acquired pneumonia (CAP), and hospital-acquired pneumonia (HAP), which includes ventilator-associated pneumonia (VAP). Healthcare-associated pneumonia (HCAP) is treated similar to HAP and may be considered with HAP. For CAP requiring hospitalization, the current guidelines for the treatments of RTIs generally recommend either a β-lactam and macrolide combination or a fluoroquinolone. The respiratory fluoroquinolones (levofloxacin, gatifloxacin, moxifloxacin, and gemifloxacin) are excellent antibiotics due to high levels of susceptibility among gram-negative, gram-positive, and atypical pathogens. The fluoroquinolones are active against >98% of Streptococcus pneumoniae, including penicillin-resistant strains. Fluoroquinolones are also recommended for AECB requiring hospitalization. Evidence from clinical trials suggests that levofloxacin monotherapy is as efficacious as combination ceftriaxone- erythromycin therapy in the treatment of patients hospitalized with CAP. For early-onset HAP, VAP, and HCAP without the risk of multidrug resistance, ceftriaxone, ampicillin-sulbactam, ertapenem, or one of the fluoroquinolones is recommended. High-dose, short-course therapy regimens may offer improved treatment due to higher drug concentrations, more rapid killing, increased adherence, and the potential to reduce development of resistance. Recent studies have shown that short-course therapy with levofloxacin, azithromycin, or telithromycin in patients with CAP was effective, safe, and tolerable and may control the rate of resistance.

Original languageEnglish (US)
Pages (from-to)29-38
Number of pages10
JournalAmerican Journal of Medicine
Issue number7 SUPPL.
StatePublished - Jul 2005


  • Antibiotics
  • Community-associated pneumonia
  • Healthcare-associated
  • Hospital-acquired
  • Quinolones
  • Ventilator-associated


Dive into the research topics of 'Antimicrobial treatment of lower respiratory tract infections in the hospital setting'. Together they form a unique fingerprint.

Cite this